NF-kappaB Signaling in Chronic Inflammatory Airway Disease.

Schuliga M. · 2015

Read NF-kappaB Signaling in Chronic Inflammatory Airway Disease. by Schuliga M. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4598751.txt.

Description

Michael Schuliga wrote a solo 2015 review of NF-kappaB signalling in long-term airway disease. Asthma and chronic obstructive pulmonary disease, or COPD, differ in cause but share airway inflammation. A protein complex called NF-kappaB switches on many inflammation genes, and oxidative stress activates it. The review appeared in the International Journal of Molecular Sciences.

Steroid drugs calm asthma partly by blocking NF-kappaB, yet in severe asthma and COPD that block fails after chemical changes to the steroid receptor and its partners. Drugs that block the enzymes which activate NF-kappaB are candidate treatments. Restoring the steroid block is another route the review weighs. Readers get a clear map of one central inflammation pathway and the treatment ideas built around it.

Catalog record

CREATORSchuliga M.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4598751

Browse the full library · About the Tower of Babel